419 studies found for:    Open Studies | "Uterine Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Uterine Diseases" (419 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Study of Laparoendoscopic Single Site Hysterectomy in Benign and Preinvasive Uterine Disease
Condition: Benign or Preinvasive Uterine Disease
Interventions: Procedure: Single-port LAVH;   Procedure: Three-port LAVH
2 Recruiting Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of SKI2670
Condition: Uterine Disease
Interventions: Drug: SKI2670;   Drug: Placebo
3 Recruiting LESS-TLH Versus LESS-LAVH
Condition: Benign Uterine Disease
Interventions: Procedure: LESS-TLH;   Procedure: LESS-LAVH
4 Recruiting The Effect on Risk-reducing Salpingectomy in Hysterectomy on Ovarian Reserve
Condition: Benign Uterine Disease
Interventions: Procedure: LH;   Procedure: RSS
5 Unknown  Study on Bladder and Sexual Function Change After Simple Hysterectomy
Condition: Benign Uterine Disease
Intervention:
6 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
7 Unknown  Screening and Identification of Biomarkers on Cervical Cancers
Condition: Cervical Cancer
Intervention: Procedure: surgery
8 Unknown  An Intervention Study To Improve HPV Immunization in Haitian and African American Girls
Condition: Cervical Cancer
Intervention: Behavioral: BNI-brief Negotiated Interview
9 Recruiting Ensuring Communication in Hospice by Oncology Study (ECHO)
Conditions: Ovarian Cancer;   Cervical Cancer;   Uterine Cancer;   Head and Neck Cancer;   Sarcoma;   Melanoma
Intervention: Behavioral: communication with oncology team
10 Recruiting Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
Conditions: Endometrial Adenoacanthoma;   Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma
Interventions: Radiation: brachytherapy;   Radiation: 3-dimensional conformal radiation therapy;   Drug: cisplatin
11 Unknown  Long-Term Outcome Following Laparoscopic Supracervical Hysterectomy Performed With and Without Excision of the Endocervix in a Reverse Cone Pattern
Condition: Vaginal Bleeding
Interventions: Device: Lapcone;   Procedure: laparoscopic supracervical hysterectomy
12 Recruiting A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia
Condition: Cervical Dysplasia
Intervention: Drug: Nelfinavir
13 Unknown  The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis
Conditions: Cervical Cancer;   Cervical Intraepithelial Neoplasia
Intervention: Procedure: peripheral blood isolation
14 Unknown  Racial and Genetic Biomarkers of Response in Tissue Samples From Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Genetic: gene expression analysis;   Other: laboratory biomarker analysis;   Other: medical chart review;   Other: study of socioeconomic and demographic variables
15 Recruiting Levonorgestrel Intrauterine Device (IUD) to Treat Complex Atypical Hyperplasia (CAH) and Grade 1 Endometrioid Endometrial Carcinoma (G1EEC)
Conditions: Hyperplasia;   Endometrial Cancer
Intervention: Device: Levonorgestrel IUD
16 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
17 Recruiting Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer
Conditions: Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Stage IB Cervical Cancer;   Stage II Vaginal Cancer;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Vaginal Cancer;   Stage IIIA Cervical Cancer;   Stage IIIB Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVA Vaginal Cancer;   Vaginal Adenocarcinoma;   Vaginal Squamous Cell Carcinoma
Interventions: Drug: triapine;   Drug: cisplatin;   Radiation: external beam radiation therapy;   Radiation: brachytherapy;   Other: laboratory biomarker analysis
18 Unknown  Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention
Condition: Cervical Cancer
Intervention: Biological: HPV Vaccine (Gardasil)
19 Recruiting Cabozantinib-S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Conditions: Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: cabozantinib-s-malate;   Other: laboratory biomarker analysis;   Other: pharmacological study
20 Unknown  Tissue Bank of Biological Specimens From Patients With Gynecologic Disease
Conditions: Endometrial Neoplasms;   Uterine Cervical Neoplasms;   Ovarian Neoplasms;   Leiomyoma
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years